AIVF, a company specializing in AI solutions for in vitro fertilization (IVF), has been recognized as one of the top 50 most promising digital health startups worldwide by CB Insights.

 

 

This acknowledgment highlights AIVF’s commitment to advancing healthcare and leading the way in IVF technology.

With its operational AI platform called EMATM, AIVF operates in 35 clinics across 14 countries, providing crucial insights that improve efficiency and patient outcomes in IVF treatments. Daniella Gilboa, CEO of AIVF, expressed gratitude for the recognition and emphasized the company’s dedication to helping IVF clinics, embryologists, and patients achieve higher success rates.

Selected from a pool of over 10,000 companies, AIVF stood out for its research and development efforts, business partnerships, investor support, and team expertise. This recognition underscores AIVF’s outstanding performance and its commitment to advancing digital health.

As the demand for fertility technologies grows worldwide, AIVF continues to innovate in the IVF field, contributing to shorter timeframes for pregnancy and enhanced clinical capabilities.

AIVF is a leader in AI-powered IVF clinics, offering a suite of solutions to digitize and automate IVF processes, making the journey to parenthood smoother, faster, and more accessible for patients.